Scope & limitations
The overview was updated in 2015 and discusses both CIPA and CIP. The form identifier 2025a-001 does not indicate an update to the medical text. The brief PDF and current webpage carry different notification numbers. Japanese application materials do not establish diagnostic or financial-support eligibility criteria elsewhere.
About these terms
- CIP
- Some resources use CIP (congenital insensitivity to pain) without the “anhidrosis” qualifier. Its scope is broader than CIPA, and this site does not treat the two as equivalent; where a resource is filed under CIP, its relationship to CIPA is stated in that record’s scope note.Based on: This site’s editorial handling (not a medical claim)
Record details
- Source organization
- Information Center for Specific Pediatric Chronic Diseases
- Regions
- Japan
- Research record date
- 2026-09-21This is not the medical revision date.
- Publication status
- Publication review complete
Title, version & context
- Index title
- CIPA in the pediatric chronic disease system
- Version & date
- Overview: version 2.0, April 16, 2015; diagnostic guidance: version 1.0, October 6, 2014, both attributed to the Japanese Society of Child Neurology. Initial and renewal medical opinion forms are marked 2025a-001.
- Source title
先天性無痛無汗症
- Relationship to CIPA
- Specifically focused on CIPA.
Reading notes
- Main audience
- Patients, families, healthcare professionals and staff working with the Japanese programme.
- Resource purpose
- Find the disease overview and application-related resources within Japan’s programme.
Individual diagnosis and support eligibility require confirmation by a physician and the relevant authority, respectively.